Eli Lilly and (LLY) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $8.38
- Estimate
- $6.58
- Surprise
- +27.3%
- Revenue (period 2026-06-30)
- $22.97B
- Score at report (before → after)
- 6.4 → 6.6/10
Revenue source: xbrl.
How the report landed
Eli Lilly and (LLY) beat the $6.58 estimate with adjusted EPS of $8.38 — a large 27.3% upside surprise. TrendMatrix's engine moved from Hold (6.4/10) to Buy (Wait) at 6.6/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates LLY Hold at 6.2/10.
4 of the last 4 quarters beat the estimate; this quarter's +27.3% surprise compares with a +20.0% four-quarter average. Next scheduled report: 2027-02-03.
What supports the rating
- Strong earnings beat streak (4/4)
- High-quality business
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (1.9% away)
- Leverage penalty (D/E 1.2): -0.5
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $1425.55
- Entry target
- $1375.04
- Stop
- $1278.79
The stock trades at 46.7× trailing but 28.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 74 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-11-13 — shown for context, not personalized investment advice.
LLY at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $1280.26B
- P/E (fwd)
- 28.4
- P/E (ttm)
- 46.7
- 52-week range
- $850.51–$1453.00
- Off 52-week high
- 1.9%
- RSI (14)
- 74
- Volume vs avg
- 0.81×
- Score today
- 6.2/10